Minidose aspirin and gastrointestinal bleeding - A retrospective, case-control study in hospitalized patients

Digestive Diseases and Sciences

Volumn 50, Issue 9, 2005, Pages 1621-1624

  Sapoznikov, Boris ^a   Vilkin, Alex ^a   Hershkovici, Marcella ^a   Fishman, Michal ^a   Eliakim, Rami ^b   Niv, Yaron ^a,c  

^a TEL AVIV UNIVERSITY   (Israel)

^b RAMBAM MEDICAL CENTER   (Israel)

^c RABIN MEDICAL CENTER   (Israel)

Author keywords

Erosions; Gastrointestinal bleeding; Gastropathy; Minidose aspirin; NSAIDs; Ulcer

Indexed keywords

ACETYLSALICYLIC ACID; NONSTEROID ANTIINFLAMMATORY AGENT; PROTECTIVE AGENT;

ADULT; AGED; ARTICLE; BLOOD TRANSFUSION; CONTROLLED STUDY; DISEASE ASSOCIATION; DIZZINESS; DRUG DOSE REGIMEN; DRUG USE; FEMALE; GASTROINTESTINAL HEMORRHAGE; GROUPS BY AGE; HEMATEMESIS; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MELENA; MULTIVARIATE ANALYSIS; PATIENT; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; CASE-CONTROL STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GASTROINTESTINAL HEMORRHAGE; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; RETROSPECTIVE STUDIES; RISK FACTORS; STOMACH DISEASES;

EID: 23944506639     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-005-2906-0     Document Type: Article

References (22)

1. Cryer B: Nonsteroidal anti-inflammatory drug injury. In Sleisenger & Fordtran's, 7th ed. Philadelphia, Saunders, 2002, pp 408-430
2. Aspirin Myocardial Infarction Study Research Group: A randomized, controlled trial of aspirin in patients recovered from myocardial infarction. JAMA243:661-669, 1980
3. Slattery J, Warlow CP, Shorrock CJ, Langman MJS: Risks of gastrointestinal bleeding during secondary prevention of vascular events with aspirin - Analysis of gastrointestinal bleeding during the UK-TIA trial. Gut 37:509-511, 1995
4. Lanas A, Bajador E, Serrano P, et al.: Nitrovasodilators, low dose aspirin, other nonsteroidal anti-inflammatory drugs, and the risk of upper gastrointestinal bleeding. N Engl J Med 348:834-839, 2000
5. Kelly JP, Kaufman DW, Jurgelon JM, et al.: Risk of aspirin-associated major upper-gastrointestinal bleeding with enteric-coated or buffered product. Lancet 348:1413-1416, 1996
6. Cryer B, Luk G, Feldman M: Effects of very low doses of aspirin on gastric, duodenal and rectal prostaglandins and mucosal injury. Gastroenterology 108:A77, 1995
7. Feldman M, Shewmake K, Cryer B: Time course inhibition of gastric and platelet COX activity by acetylsalicylic acid in humans. Am J Physiol Gastrointest Liver Physiol 279:G1113-G1120, 2000
8. ISIS-2 (Secondary International Study of Infarct Survival) Collaborative Group: Randomised trial of intravenous streptokinase, oral aspirin, both or neither among 17187 cases of suspected acute myocardial infarction: ISIS-2. Lancet 13:349-360, 1988
9. Antithrombotic Trials' Collaboration: Collaborative meta-analysis of randomized trials of antiplatelet therapy for prevention of death, myocardial infarction and stroke in high-risk patients. BMJ 324:71-86, 2002
10. Hung J: Medical Issues Committee of the National Heart Foundation of Australia. Aspirin for cardiovascular disease prevention. Med J Austral 179:147-152, 2003
11. Tarnawski AS, Caves TC: Aspirin in the XXI century: Its major clinical impact, novel mechanisms of action, and new safer formulations. Gastroenterology 127:341-343, 2004
12. Baskin WN, Ivey KJ, Krause WJ, et al.: Aspirin-induced ultrastructural changes in human gastric mucosa: comparison with potential difference. Ann Intern Med 85:299-303, 1976
13. Darling RL, Romero JJ, Dial EJ, Akunda JK, Langenbach R, Lichtenberger LM: The effect of aspirin on gastric mucosal integrity, surface hydrophobicity, and prostaglandin metabolism in cyclooxygenase knockout mice. Gastroenterology 127:94-104, 2004
14. Singh G, Triadafilopoulos G: Epidemiology of NSAID-induced GI complications. J Rheumatol 26(Suppl 26):18-24, 1999
15. Singh G, Ramey DR: NSAID induced gastrointestinal complications: The ARAMIS perspective. J Rheumatol 25:8-16, 1998
16. Silverstein FE, Graham DY, Senior JR, et al.: Misoprostol reduces serious gastrointestinal complications in patients with rheumatoid arthritis receiving nonsteroidal anti-inflammatory drugs: A randomized, double-blind, placebo-controlled trial. Ann Intern Med 123:241-249, 1995
17. Silverstein FE, Faich G, Goldstein JL, et al.: Gastrointestinal toxicity with celecoxib vs. nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: The CLASS study: A randomized controlled trial. JAMA 284:1247-1255, 2000
18. Bombardier C, Laine L, Reicin A, et al.: Rofecoxib and naproxen in patients with rheumatoid arthritis. N Engl J Med 343:1520-1528, 2000
19. Gabriel SE, Jaakkimainen L, Bombardier C: Risk for serious gastrointestinal complications related to use of nonsteroidal anti-inflammatory drugs. Ann Intern Med 115:787-796, 1991
20. Rodrigues LAG, Jick H: Risk of upper gastrointestinal bleeding and perforation associated with individual nonsteroidal anti-inflammatory drugs. Lancet 343:769-772, 1994
21. Yeomans ND, Tullasay Z, Juhasz L: A comparison of omeprazole with ranitidine for ulcers associated with nonsteroidal anti-inflammatory drugs. N Engl J Med 338:719-726, 1998
22. Hawkey CJ, Karrasch JA, Szczepanski L: Omeprazole compared with misoprostol for ulcers associated with nonsteroidal anti-inflammatory drugs. N Engl J Med 338:727-734, 1998